KRD posted on the CUV board in Australia that the SP of CLVLY went up $0,45! What he forgot to mention that it wasn't supported by good volume, only support by a very, very low volume, somewhat over the 3300!!!
Very tricky.
Technical spoken this is called "a False Break-out" Be warned. This upward momentum is not supported. I think it's only ment to give you the idea that CUV is in the uptrend again, which she isn't. The outcome of NICE in the UK gonna hearth this stock next year. At least it will take another year before Scenesse will be on the Market in the UK.
Pricing is one of the discussionpoints in the UK. Furthermore NICE isn't convinced that Afamelanotide is a Life-Changer for the EPP Patient.
About pricing. PW clearly stated Uniforming pricing is one of his goals. He has to keep this under control. If not he will get in big problems. Then it's payback time for all those countries who paid already the full some, like Holland!!!!!
In other words the talks in the UK perhaps will take more then one year from now! Let's say beginning 2019 Clinuvel gets green light in the UK. Then Scenesse isn't still on the Market in the UK!!
It will take at least 3 months, by the end of March when I'm right before we will hear any substainable news from PW. That's 3 months, sitting in The Waiting Room. Technical spoken the SP still is in the downtrend.
Technical spoken the first real supportlevel is in the low $4's.
Let's be clear. this is my personal view.
